Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Quizartinib with donor lymphocyte infusion for post-transplant relapse of FLT3-ITD-positive acute myeloid leukemia.

Autor: Ouchi F; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan., Shingai N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan., Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan. yuhonajima@gmail.com., Sadato D; Clinical Research Support Center, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Hirama C; Clinical Research Support Center, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Wakita S; Department of Hematology, Nippon Medical School, Tokyo, Japan., Kondo K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan., Sadaga Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan., Kato C; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan., Sakai S; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan., Kambara Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan., Shimabukuro M; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan., Inai K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan.; Department of Hematology, Nippon Medical School, Tokyo, Japan., Toya T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan., Shimizu H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan., Haraguchi K; Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Kobayashi T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan., Harada H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan.; Laboratory of Oncology, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Okuyama Y; Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Yamaguchi H; Department of Hematology, Nippon Medical School, Tokyo, Japan., Harada Y; Clinical Research Support Center, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-8-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan.

Publikováno v: International journal of hematology [Int J Hematol] 2024 Oct 26. Date of Electronic Publication: 2024 Oct 26.

[Ruptured mycotic cerebral aneurysm in an adult T-cell leukemia/lymphoma patient undergoing allogeneic stem cell transplantation].

Autor: Koi S; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Shimizu H; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Sadaga Y; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Kondo K; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Kato C; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Sakai S; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Kambara Y; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Konuma R; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Atsuta Y; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Shimabukuro M; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Jinguji A; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Hosoda Y; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Onai D; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Hamamura A; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Shingai N; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Toya T; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Najima Y; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Kobayashi T; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Matsuzawa Y; Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Arai H; Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Sekiya N; Department of Infection Control, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Haraguchi K; Department of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Okuyama Y; Department of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital., Doki N; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital.

Publikováno v: [Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2024; Vol. 65 (2), pp. 84-89.